Hologic [HOLX] vs ResMed [RMD] Detailed Stock Comparison

Hologic Inc.

NASDAQ
Loading...

ResMed Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Hologic Inc. wins in 7 metrics, ResMed Inc. wins in 13 metrics, with 0 ties. ResMed Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Hologic Inc. ResMed Inc. Better
P/E Ratio (TTM) 31.54 21.69 ResMed Inc.
Price-to-Book Ratio 3.23 5.06 Hologic Inc.
Debt-to-Equity Ratio 48.05 13.41 ResMed Inc.
PEG Ratio -3.92 1.50 ResMed Inc.
EV/EBITDA 12.68 15.51 Hologic Inc.
Profit Margin (TTM) 13.18% 27.53% ResMed Inc.
Operating Margin (TTM) 22.99% 35.16% ResMed Inc.
EBITDA Margin (TTM) 22.99% 35.16% ResMed Inc.
Return on Equity 10.86% 25.68% ResMed Inc.
Return on Assets (TTM) 7.43% 14.75% ResMed Inc.
Free Cash Flow (TTM) $904.70M $1.65B ResMed Inc.
Dividend Yield N/A 0.92% N/A
1-Year Return 31.39% -21.88% Hologic Inc.
Price-to-Sales Ratio (TTM) 4.11 5.92 Hologic Inc.
Enterprise Value $17.12B $31.41B ResMed Inc.
EV/Revenue Ratio 4.15 5.82 Hologic Inc.
Gross Profit Margin (TTM) 55.96% 61.76% ResMed Inc.
Revenue per Share (TTM) $18 $37 ResMed Inc.
Earnings per Share (Diluted) $2.41 $10.12 ResMed Inc.
Beta (Stock Volatility) 0.70 0.93 Hologic Inc.
Short % of Float 3.66% 9.40% Hologic Inc.

Hologic Inc. vs ResMed Inc. Stock Performance Analysis

Loading Price Chart...

HOLX
RMD

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Hologic Inc.0.00%0.56%0.56%1.40%12.23%1.94%
ResMed Inc.-1.05%-0.21%-4.53%-16.42%-23.84%-21.27%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Hologic Inc.31.39%-9.66%-0.85%110.15%246.29%206.74%
ResMed Inc.-21.88%-11.08%-17.97%233.76%527.92%775.81%

Performance & Financial Health Analysis: Hologic Inc. vs ResMed Inc.

MetricHOLXRMD
Market Information
Market Cap i$16.97B$32.03B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i12,273,085955,842
90 Day Avg. Volume i6,282,6251,020,554
Last Close$76.01$192.74
52 Week Range$51.90 - $76.07$180.27 - $293.81
% from 52W High-0.08%-34.40%
All-Time High$87.88 (May 01, 2023)$301.34 (Sep 06, 2021)
% from All-Time High-13.51%-36.04%
Growth Metrics
Quarterly Revenue Growth0.03%0.11%
Quarterly Earnings Growth-0.11%0.14%
Financial Health
Profit Margin (TTM) i0.13%0.28%
Operating Margin (TTM) i0.23%0.35%
Return on Equity (TTM) i0.11%0.26%
Debt to Equity (MRQ) i48.0513.41
Cash & Liquidity
Book Value per Share (MRQ)$23.51$43.39
Cash per Share (MRQ)$10.60$9.73
Operating Cash Flow (TTM) i$1.10B$1.91B
Levered Free Cash Flow (TTM) i$848.61M$1.42B
Dividends
Last 12-Month Dividend Yield iN/A0.92%
Last 12-Month Dividend iN/A$2.33

Valuation & Enterprise Metrics Analysis: Hologic Inc. vs ResMed Inc.

MetricHOLX (Apr 19, 2026)RMD (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i31.5421.69
Forward P/E i15.6418.02
PEG Ratio i-3.921.50
Price to Sales (TTM) i4.115.92
Price to Book (MRQ) i3.235.06
Market Capitalization
Market Capitalization i$16.97B$32.03B
Enterprise Value i$17.12B$31.41B
Enterprise Value Metrics
Enterprise to Revenue i4.155.82
Enterprise to EBITDA i12.6815.51
Risk & Other Metrics
Beta i0.700.93
Book Value per Share (MRQ) i$23.51$43.39

Financial Statements Comparison: Hologic Inc. vs ResMed Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricHOLX (2025)RMD (2025)
Revenue/Sales i4.10B5.15B
Cost of Goods Sold i1.98B2.09B
COGS % of Revenue i48.4%40.6%
Gross Profit i2.12B3.05B
Gross Margin i51.6%59.4%
Research & Development i248.20M331.28M
Operating Income (EBIT) i785.40M1.69B
Operating Margin i19.2%32.8%
EBITDA i1.17B1.93B
EBITDA Margin i28.5%37.4%
Pre-Tax Income i681.20M1.68B
Pre-Tax Income % of Revenue i16.6%32.6%
Income Tax i115.50M276.84M
Income Tax % of Revenue i2.8%5.4%
Net Income (Profit) i565.70M1.40B
Profit Margin i13.8%27.2%

Balance Sheet & Liquidity Metrics

MetricHOLX (2025)RMD (2025)
Cash & Equivalents i1.96B1.21B
Total Current Assets i3.67B3.51B
Total Current Assets % of Revenue i89.5%68.1%
Total Current Liabilities i977.20M1.02B
Total Current Liabilities % of Revenue i23.8%19.8%
Long-Term Debt i2.59B811.41M
Long-Term Debt % of Revenue i63.2%15.8%
Total Shareholders Equity i5.05B5.97B
Retained Earnings i3.41B6.08B
Retained Earnings % of Revenue i83.2%118.2%
Property, Plant & Equipment i1.07B288.62M

Cash Flow Statement Comparison

MetricHOLX (2025)RMD (2025)
Operating Cash Flow i831.50M1.57B
Operating Cash Flow % of Revenue i20.3%30.5%
Capital Expenditures i-78.20M-89.87M
Free Cash Flow i904.70M1.65B
FCF Margin i22.1%32.1%
Debt Repayment i-1.20B-40.00M
Common Stock Repurchase i-752.90M-300.03M

Short Interest & Institutional Ownership Analysis

MetricHOLXRMD
Shares Short i7.10M11.89M
Short Ratio i2.7811.24
Short % of Float i3.66%9.40%
Shares Outstanding i223.07M145.66M
Float Shares i221.21M144.79M
% Held by Insiders i0.84%0.50%
% Held by Institutions i96.52%68.82%
% Held by Public i2.64%30.68%

Dividend Analysis & Yield Comparison: Hologic Inc. vs ResMed Inc.

MetricHOLXRMD
Last 12-Month Dividend iN/A$2.33
Last 12-Month Dividend Yield iN/A0.92%
3-Year Avg Annual Dividend iN/A$2.09
3-Year Avg Dividend Yield iN/A0.24%
3-Year Total Dividends iN/A$6.28
Ex-Dividend DateN/AFeb 12, 2026